A New Era for Urticaria Treatment episode artwork

EPISODE · Dec 18, 2025 · 5 MIN

A New Era for Urticaria Treatment

from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier · host UCARE, the Global Allergy and Asthma Excellence Network for Urticaria

In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the UCARE Urticaria Conference, sharing the latest breakthroughs in urticaria research and treatment. The discuss: 🔹 What are the most important new developments in urticaria therapy? 🔹 How do BTK inhibitors change the way chronic urticaria is treated? 🔹 Why can these new drugs work in both autoimmune and autoallergic urticaria? 🔹 How can digital tools like the CRUSE App support patients and physicians? Professor Godse highlights the rapid progress made over the past year, including the emergence of novel oral therapies that caneffectively control most forms of chronic urticaria. The discussion focuses on BTK inhibitors, which act inside the mast cell to block histamine release at its source, offering a new, convenient tablet-based treatment option. In addition, the episode emphasizes the growing role of digital patient tools, such as the CRUSE App, which help patients monitor disease activity and support personalized treatment decisions worldwide.Key Learnings from the Episode:Chronic urticaria consists of autoallergic and autoimmune subtypes, both of which can be targeted by new BTK inhibitors. BTK inhibitors block mast-cell signaling inside the cell, preventing histamine release and reducing symptoms effectively. New oral therapies offer once- or twice-daily tablet options, improving convenience and adherence for patients. Several new urticaria treatments have been approved globally, with wider availability expected soon. The CRUSE App enables patients to track disease activity and supports data-driven clinical decisions. Digital tools improve doctor–patient communication and help personalize treatment strategies. Global initiatives like UCARE are transforming urticaria care through research, education, and collaboration. The outlook for urticaria patients is increasingly positive, with more effective and accessible treatments emerging worldwide. Chapters:00:00 Introduction to UCARE Conference01:31 New Developments in Urticaria Treatment03:22 Innovative Apps for Patient ManagementDo you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.   Feedback form: ATU: ⁠⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

Episode metadata supplied by the publisher feed · Published Dec 18, 2025

Embed this episode

NOW PLAYING

A New Era for Urticaria Treatment

0:00 5:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier?

This episode is 5 minutes long.

When was this All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier episode published?

This episode was published on December 18, 2025.

Can I download this All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!